This week's topics: The most disruptive tech development you've never heard of; Pso and OCD link; Arcutis' roflumilast trial shows positive AD data; Happy Urticaria Day to all; and much more
Share this post
Dermatology.Business Deep Dive 10-23-24
Share this post
This week's topics: The most disruptive tech development you've never heard of; Pso and OCD link; Arcutis' roflumilast trial shows positive AD data; Happy Urticaria Day to all; and much more